Atul Pande

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Immunovant Inc., 3 years.

Immunovant Inc. Director
3 years · Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 28, 2026 Immunovant Inc. Option exercise +1,500 $8.43 $12,645
Aug 28, 2026 Immunovant Inc. Open-market sale −1,500 $43.27 $64,905
Jul 24, 2026 Immunovant Inc. Option exercise +1,500 $8.43 $12,645
Jul 24, 2026 Immunovant Inc. Open-market sale −1,500 $39.80 $59,700
Jun 26, 2026 Immunovant Inc. Option exercise +1,500 $8.43 $12,645
Jun 26, 2026 Immunovant Inc. Open-market sale −1,500 $38.01 $57,015
Jun 15, 2026 Immunovant Inc. Option exercise +1,500 $8.43 $12,645
Jun 15, 2026 Immunovant Inc. Open-market sale −1,500 $34.02 $51,030
May 20, 2026 Immunovant Inc. Option exercise +6,000 $8.43 $50,580
May 20, 2026 Immunovant Inc. Open-market sale −6,000 $32.00 $192,000
Apr 7, 2026 Immunovant Inc. Grant or award +13,880 — —
Apr 1, 2025 Immunovant Inc. Grant or award +16,188 — —
Dec 2, 2024 Immunovant Inc. Open-market sale −7,750 $28.54 $221,185
Apr 2, 2024 Immunovant Inc. Grant or award +11,255 — —
Dec 1, 2023 Immunovant Inc. Open-market sale −4,129 $38.80 $160,205

Questions about Atul Pande

What boards is Atul Pande on?

Atul Pande sits on the board of Immunovant Inc.

How long has Atul Pande served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.